Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower Urinary Tract Symptoms
|
30 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Blood Coagulation Disorders
|
31 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Bronchiolitis
|
32 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2012 | 2020 | |||||
Fatty Liver
|
35 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||
Virus Diseases
|
42 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Myeloproliferative disease
|
43 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Iron Overload
|
53 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Pseudohyperkalemia Cardiff
|
60 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.100 | 0.933 | 15 | 2011 | 2019 | |||||
Fibrosis, Liver
|
64 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.070 | 1.000 | 7 | 2010 | 2019 | |||||
X-linked Adrenal Hypoplasia
|
70 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Steatohepatitis
|
75 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||
Hepatitis C, Chronic
|
80 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.900 | 1.000 | 18 | 2009 | 2019 | |||||
Hepatitis B, Chronic
|
84 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Anemia
|
94 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Complete atrioventricular block
|
96 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.040 | 1.000 | 4 | 2013 | 2019 | |||||
Chronic Periodontitis
|
99 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Liver diseases
|
100 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.060 | 1.000 | 6 | 2011 | 2017 | |||||
beta Thalassemia
|
103 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Cirrhosis
|
110 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Huntington Disease
|
115 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Hashimoto Disease
|
131 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Hodgkin Disease
|
148 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Allergic rhinitis (disorder)
|
176 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1 | 2017 | 2017 | ||||||
Liver Cirrhosis
|
189 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.030 | 0.667 | 3 | 2012 | 2017 |